In vitro drug resistance as important prognostic factor in two prospective studies in childhood all.

被引：0
|
作者：
Kaspers, GJL
DenBoer, ML
Pieters, R
Janka, G
VanWering, ER
VanderdoesvandenBerg, A
Veerman, AJP
机构：
[1] VRIJE UNIV AMSTERDAM,ACAD HOSP,AMSTERDAM,NETHERLANDS
[2] COALL STUDY GRP,HAMBURG,GERMANY
[3] DUTCH CHILDHOOD LEUKEMIA STUDY GRP,THE HAGUE,NETHERLANDS
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2521 / 2521
页数：2
相关论文
共 50 条
  • [1] In vitro drug resistance and the expression of ABC-transporters in childhood ALL.
    Steinbach, D
    Friedrich, J
    Wittig, S
    Gruhn, B
    Zintl, F
    Sauerbrey, A
    [J]. BLOOD, 2003, 102 (11) : 861A - 861A
  • [2] Numerical chromosomal abnormalities in relation to in vitro cellular drug resistance in childhood ALL.
    Kaspers, GJL
    Ramakers-van Woerden, NL
    Pieters, R
    Rots, MG
    Van Wering, ER
    Loonen, AH
    Slater, R
    Harbott, J
    Schmiegelow, K
    Janka-Schaub, GE
    Veerman, AJP
    [J]. BLOOD, 2002, 100 (11) : 320A - 320A
  • [3] In vitro drug resistance in childhood ALL and its relation with the prognostic factors
    Karakas, Z
    Kuruca, SE
    Akcay, A
    Atasever, B
    Aydogan, G
    Bulbul, A
    Goksan, B
    Gedikoglu, G
    [J]. LEUKEMIA, 2003, 17 (03) : 680 - 680
  • [4] IN-VITRO DRUG-RESISTANCE PROFILE - STRONGEST PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    KASPERS, GJL
    VEERMAN, AJP
    PIETERS, R
    VANZANTWIJK, CH
    VANWERING, ER
    VANDERDOESVANDENBERG, A
    [J]. BLOOD, 1994, 84 (10) : A516 - A516
  • [5] Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia?
    Styczynski, J
    Wysocki, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 963 - 964
  • [6] Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood all.
    Kanerva, J
    SaarinenPihkala, UM
    Riikonen, P
    Makipernaa, A
    Mottonen, M
    Salmi, TT
    [J]. BLOOD, 1997, 90 (10) : 3702 - 3702
  • [7] Residual disease after induction Therapy in Childhood ALL.: 'a highly significant prognostic factor'
    Cavé, H
    ten Bosch, JV
    Suciu, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (13) : 1989 - 1990
  • [8] p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood ALL.
    Dalle, JH
    Fournier, M
    Nelken, B
    Mazingue, F
    Laï, JL
    Bauters, F
    Fenaux, P
    Quesnel, B
    [J]. BLOOD, 2001, 98 (11) : 314A - 314A
  • [9] Prognostic value of minimal residual disease in relapsed childhood ALL.
    Eckert, C
    Biondi, A
    Seeger, K
    Cazzaniga, G
    Hartmann, R
    Proba, J
    D'Aniello, E
    Beyermann, B
    Seifert, G
    Henze, G
    [J]. BLOOD, 2000, 96 (11) : 315A - 315A
  • [10] Prognostic value of real time quantitative minimal residual disease detection within an in-vitro-drug-resistance-profile stratified therapeutic regimen in childhood precursor B-cell ALL.
    zur Stadt, U
    Naecker, A
    Escherich, G
    Golta, S
    Pieters, R
    den Boer, M
    Janka, G
    Kabisch, H
    [J]. BLOOD, 2003, 102 (11) : 605A - 606A
12345